# K111717: Electro-Gel

- Pathway: 510(k) (Traditional)
- Applicant: Electro-Cap Intl., Inc.
- Decided: Jan 5, 2012 after 199 days
- Product code: GYB (Media, Electroconductive)
- Device class: 2
- Regulation: 21 CFR 882.1275
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K983964 (1998). 6 ancestors in all.
8 later devices descend from it; 4 cite it directly.
0 of 15 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K780045: Electrode Cap, Electro-Cap Intl., Inc. (1978) Summary page 1.
- K883149: TEN20 Conductive, Weaver & Co. (1988) Summary page 1.
- K003924: Mavidon Medical Electrode Jelly, Mavidon Medical Products (2001) Summary page 1.
- K033052: Conductive Eeg Electrolyte, Compumedics USA, Ltd. (2003) Summary page 1.

## Most influential descendants
- K190050: Tech Dots - Adhesive and conductive gel (2019), 6 descendants of its own
- K192606: SAC2 - Electrode Cream (2020), 2 descendants of its own
- K161715: EndyGel (2017), 2 descendants of its own
- K200402: DR-HO'S Electro Therapy Conductive Gel (2020), 1 descendant of its own
- K222770: Conductive Gel (2022), 0 descendants of its own

## Indications for use
Electro-Giel is intended for use in clinical and research EEG/EP recordings from humans. It is used with external electrodes as the conductor between the scalp and the (recessed) electrodes. It also reduces impedance (resistance to alternating current) between the electrode surface and the skin.

Source page: https://510kreport.com/device/K111717
Methodology: https://510kreport.com/methodology